News | September 28, 2023
Sun Pharma Canada launches Prwinlevi for treatment for acne
WINLEVI works differently from any other topical acne treatment
WINLEVI works differently from any other topical acne treatment
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Construction will begin this year with the new capacity anticipated by 2025
New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
The new sterile filling line meets cGMP aseptic filling regulatory requirements
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Subscribe To Our Newsletter & Stay Updated
